Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective

INTRODUCTION: Our aim was to develop consensus guidelines for use of recombinant activated factor VII (rFVIIa) in massive hemorrhage. METHODS: A guidelines committee derived the recommendations using clinical trial and case series data identified through searches of available databases. Guidelines w...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincent, Jean-Louis, Rossaint, Rolf, Riou, Bruno, Ozier, Yves, Zideman, David, Spahn, Donat R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1750973/
https://www.ncbi.nlm.nih.gov/pubmed/16919168
http://dx.doi.org/10.1186/cc5026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1750973/
https://www.ncbi.nlm.nih.gov/pubmed/16919168
http://dx.doi.org/10.1186/cc5026

Ejemplares similares